table of content
1 Introduction to Research & Analysis Reports
1.1 Nonalcoholic Steatohepatitis (NASH) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nonalcoholic Steatohepatitis (NASH) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nonalcoholic Steatohepatitis (NASH) Overall Market Size
2.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size: 2022 VS 2029
2.2 Global Nonalcoholic Steatohepatitis (NASH) Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nonalcoholic Steatohepatitis (NASH) Players in Global Market
3.2 Top Global Nonalcoholic Steatohepatitis (NASH) Companies Ranked by Revenue
3.3 Global Nonalcoholic Steatohepatitis (NASH) Revenue by Companies
3.4 Top 3 and Top 5 Nonalcoholic Steatohepatitis (NASH) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Nonalcoholic Steatohepatitis (NASH) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nonalcoholic Steatohepatitis (NASH) Players in Global Market
3.6.1 List of Global Tier 1 Nonalcoholic Steatohepatitis (NASH) Companies
3.6.2 List of Global Tier 2 and Tier 3 Nonalcoholic Steatohepatitis (NASH) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Nonalcoholic Steatohepatitis (NASH) Market Size Markets, 2022 & 2029
4.1.2 Obeticholic acid?OCA?
4.1.3 Selonsertib
4.2 By Type - Global Nonalcoholic Steatohepatitis (NASH) Revenue & Forecasts
4.2.1 By Type - Global Nonalcoholic Steatohepatitis (NASH) Revenue, 2018-2023
4.2.2 By Type - Global Nonalcoholic Steatohepatitis (NASH) Revenue, 2024-2029
4.2.3 By Type - Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nonalcoholic Steatohepatitis (NASH) Market Size, 2022 & 2029
5.1.2 Hospital Pharmacy
5.1.3 Online Provider
5.1.4 Retail Pharmacy
5.2 By Application - Global Nonalcoholic Steatohepatitis (NASH) Revenue & Forecasts
5.2.1 By Application - Global Nonalcoholic Steatohepatitis (NASH) Revenue, 2018-2023
5.2.2 By Application - Global Nonalcoholic Steatohepatitis (NASH) Revenue, 2024-2029
5.2.3 By Application - Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Nonalcoholic Steatohepatitis (NASH) Market Size, 2022 & 2029
6.2 By Region - Global Nonalcoholic Steatohepatitis (NASH) Revenue & Forecasts
6.2.1 By Region - Global Nonalcoholic Steatohepatitis (NASH) Revenue, 2018-2023
6.2.2 By Region - Global Nonalcoholic Steatohepatitis (NASH) Revenue, 2024-2029
6.2.3 By Region - Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Nonalcoholic Steatohepatitis (NASH) Revenue, 2018-2029
6.3.2 US Nonalcoholic Steatohepatitis (NASH) Market Size, 2018-2029
6.3.3 Canada Nonalcoholic Steatohepatitis (NASH) Market Size, 2018-2029
6.3.4 Mexico Nonalcoholic Steatohepatitis (NASH) Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Nonalcoholic Steatohepatitis (NASH) Revenue, 2018-2029
6.4.2 Germany Nonalcoholic Steatohepatitis (NASH) Market Size, 2018-2029
6.4.3 France Nonalcoholic Steatohepatitis (NASH) Market Size, 2018-2029
6.4.4 U.K. Nonalcoholic Steatohepatitis (NASH) Market Size, 2018-2029
6.4.5 Italy Nonalcoholic Steatohepatitis (NASH) Market Size, 2018-2029
6.4.6 Russia Nonalcoholic Steatohepatitis (NASH) Market Size, 2018-2029
6.4.7 Nordic Countries Nonalcoholic Steatohepatitis (NASH) Market Size, 2018-2029
6.4.8 Benelux Nonalcoholic Steatohepatitis (NASH) Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Nonalcoholic Steatohepatitis (NASH) Revenue, 2018-2029
6.5.2 China Nonalcoholic Steatohepatitis (NASH) Market Size, 2018-2029
6.5.3 Japan Nonalcoholic Steatohepatitis (NASH) Market Size, 2018-2029
6.5.4 South Korea Nonalcoholic Steatohepatitis (NASH) Market Size, 2018-2029
6.5.5 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size, 2018-2029
6.5.6 India Nonalcoholic Steatohepatitis (NASH) Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Nonalcoholic Steatohepatitis (NASH) Revenue, 2018-2029
6.6.2 Brazil Nonalcoholic Steatohepatitis (NASH) Market Size, 2018-2029
6.6.3 Argentina Nonalcoholic Steatohepatitis (NASH) Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Revenue, 2018-2029
6.7.2 Turkey Nonalcoholic Steatohepatitis (NASH) Market Size, 2018-2029
6.7.3 Israel Nonalcoholic Steatohepatitis (NASH) Market Size, 2018-2029
6.7.4 Saudi Arabia Nonalcoholic Steatohepatitis (NASH) Market Size, 2018-2029
6.7.5 UAE Nonalcoholic Steatohepatitis (NASH) Market Size, 2018-2029
7 Nonalcoholic Steatohepatitis (NASH) Companies Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Nonalcoholic Steatohepatitis (NASH) Major Product Offerings
7.1.4 AstraZeneca Nonalcoholic Steatohepatitis (NASH) Revenue in Global Market (2018-2023)
7.1.5 AstraZeneca Key News & Latest Developments
7.2 Arena Pharmaceuticals
7.2.1 Arena Pharmaceuticals Company Summary
7.2.2 Arena Pharmaceuticals Business Overview
7.2.3 Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Major Product Offerings
7.2.4 Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue in Global Market (2018-2023)
7.2.5 Arena Pharmaceuticals Key News & Latest Developments
7.3 GSK
7.3.1 GSK Company Summary
7.3.2 GSK Business Overview
7.3.3 GSK Nonalcoholic Steatohepatitis (NASH) Major Product Offerings
7.3.4 GSK Nonalcoholic Steatohepatitis (NASH) Revenue in Global Market (2018-2023)
7.3.5 GSK Key News & Latest Developments
7.4 Novo Nordisk
7.4.1 Novo Nordisk Company Summary
7.4.2 Novo Nordisk Business Overview
7.4.3 Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Major Product Offerings
7.4.4 Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Revenue in Global Market (2018-2023)
7.4.5 Novo Nordisk Key News & Latest Developments
7.5 Roche
7.5.1 Roche Company Summary
7.5.2 Roche Business Overview
7.5.3 Roche Nonalcoholic Steatohepatitis (NASH) Major Product Offerings
7.5.4 Roche Nonalcoholic Steatohepatitis (NASH) Revenue in Global Market (2018-2023)
7.5.5 Roche Key News & Latest Developments
7.6 Vivus
7.6.1 Vivus Company Summary
7.6.2 Vivus Business Overview
7.6.3 Vivus Nonalcoholic Steatohepatitis (NASH) Major Product Offerings
7.6.4 Vivus Nonalcoholic Steatohepatitis (NASH) Revenue in Global Market (2018-2023)
7.6.5 Vivus Key News & Latest Developments
7.7 Arisaph Pharmaceuticals
7.7.1 Arisaph Pharmaceuticals Company Summary
7.7.2 Arisaph Pharmaceuticals Business Overview
7.7.3 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Major Product Offerings
7.7.4 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue in Global Market (2018-2023)
7.7.5 Arisaph Pharmaceuticals Key News & Latest Developments
7.8 Cempra Pharmaceuticals
7.8.1 Cempra Pharmaceuticals Company Summary
7.8.2 Cempra Pharmaceuticals Business Overview
7.8.3 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Major Product Offerings
7.8.4 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue in Global Market (2018-2023)
7.8.5 Cempra Pharmaceuticals Key News & Latest Developments
7.9 Galectin Therapeutics
7.9.1 Galectin Therapeutics Company Summary
7.9.2 Galectin Therapeutics Business Overview
7.9.3 Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Major Product Offerings
7.9.4 Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue in Global Market (2018-2023)
7.9.5 Galectin Therapeutics Key News & Latest Developments
7.10 Galmed Pharmaceuticals
7.10.1 Galmed Pharmaceuticals Company Summary
7.10.2 Galmed Pharmaceuticals Business Overview
7.10.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Major Product Offerings
7.10.4 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue in Global Market (2018-2023)
7.10.5 Galmed Pharmaceuticals Key News & Latest Developments
7.11 Genfit
7.11.1 Genfit Company Summary
7.11.2 Genfit Business Overview
7.11.3 Genfit Nonalcoholic Steatohepatitis (NASH) Major Product Offerings
7.11.4 Genfit Nonalcoholic Steatohepatitis (NASH) Revenue in Global Market (2018-2023)
7.11.5 Genfit Key News & Latest Developments
7.12 Gilead
7.12.1 Gilead Company Summary
7.12.2 Gilead Business Overview
7.12.3 Gilead Nonalcoholic Steatohepatitis (NASH) Major Product Offerings
7.12.4 Gilead Nonalcoholic Steatohepatitis (NASH) Revenue in Global Market (2018-2023)
7.12.5 Gilead Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
